Reply To the Editor, Re: Bicakli et al. Adjuvant chemotherapy may contribute to an increased risk for metabolic syndrome in patients with breast cancer. J Oncol Pharm Pract, published online September 2014. DOI: 10.1177/1078155214551315
Source: Journal of Oncology Pharmacy Practice - Category: Cancer & Oncology Authors: Bicakli, D. H., Varol, U., Degirmenci, M., Tunali, D., Cakar, B., Durusoy, R., Karaca, B., Sanli, U. A., Uslu, R. Tags: Letters to the Editor Source Type: research